Swiss National Strategy for ME/CFS and Long Covid
Recently we reported that the Swiss Council of States’ Commission for Social Security and Health (SGK-S) unanimously recommended the adoption of a National Strategy for ME/CFS and Long Covid, a significant step forward for patients affected by these debilitating conditions, as well as by Post-Vac Syndrome (PVS).
The motion had to pass the final hurdle when the Council of States voted during its autumn session.
On 18 September, 2025 - The Council of States met and approved the motion.
This national strategy is an urgent first step towards listening to patients who have been crying out for decades.
Switzerland is putting in place one of Europe’s first national strategies specifically dedicated to
improving care and research for ME/CFS and Long Covid.
Below is the statement released by EMEA Switzerland and other Swiss patient organisations
From EMEA Switzerland's Newsletter
As EMEA Switzerland write in their recent newsletter -
Of course, there is still a long way to go regarding the actual improvement of living conditions and medical and social security for those affected. The development of a strategy by the Federal Office of Public Health (BAG) will now take more than a year, as Federal Councillor Baume-Schneider said in her speech yesterday. However, following yesterday's historic decision, we hope for a strong initial signal effect on the various actors—and thus for more understanding and help for all affected individuals and their families.
As patient organisations, we will closely monitor how the concrete development of a strategy by the BAG proceeds and will also try to exert influence to ensure that the demands of the motion are actually implemented in the coming months and years!
Also assisting in supporting this initiative was a
book 'Über Sehen Über Leben'
by Andreas Siebert with interviews of over
80 Swiss citizens affected with these diseases. The book details their personal stories and struggles not
only with the disease but with disbelief and stigma.
EMEA Switzerland (The Swiss ME/CFS Association) gave a copy to all of the politicians supporting the strategy.
The European ME Research Group for young/early career researchers
- Young EMERG - was
pleased to contribute to the book with the section 'About ME - What it is and its impact on patients'
and which
provided a history of ME, the challenges patients and researchers face, and the current research landscape.